Superworth

Bausch Health Companies price to book ratio BHC

Market value divided by the book value of the company's net assets, since 2010.

Today, Oct 23, 2026
n/m
not a meaningful number
Last meaningful
21.4×
Apr 2021
10-year median
2.7×
10-year range
0.9× to 22.2×
Peer median
3.2×

Bausch Health Companies' price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.

It was last meaningful in Apr 2021, at 21.4×.

On the days it had one over the last ten years, its median was 2.7×, from 0.9× in Mar 2018 to 22.2× in Mar 2021.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
202121.4×14.0×22.2×
202012.6×3.9×13.8×
20194.2×2.4×4.4×
20182.1×0.9×3.0×
20171.4×0.9×1.6×
20161.2×1.2×5.2×
20155.5×4.1×13.7×
20149.3×7.0×9.9×
20137.7×4.9×8.2×
20124.7×3.4×4.9×
20113.6×2.0×3.6×
20101.6×1.4×3.2×

Against its peers

Companies in Drug Manufacturers - General nearest Bausch Health Companies' size, closest first, today.

CompanyPrice to book ratio
BHCBausch Health Companiesn/m
PBHPrestige Consumer Healthcare1.2×
HRMYHarmony Biosciences2.1×
NRIXNurix Therapeutics2.9×
ANIPANI Pharmaceuticals2.8×
OGNOrganon3.6×
PAHCPhibro Animal Health4.1×
LQDALiquidia19.6×
ARQTArcutis Biotherapeutics17.8×
ANABAnaptysbio138×
PCRXPacira BioSciences2.2×
Peer median3.2×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Bausch Health Companies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.